Related Experiment Video
Updated: Dec 26, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Arguments against using an abbreviated or biparametric prostate MRI protocol
Felipe B Franco1, Fiona M Fennessy2,3
1Department of Radiology, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02215, USA.
Abstract:
Currently there is a lot of interest in the use of a "biparametric" or "abbreviated" prostate MR protocol, which usually refers to removal of the dynamic contrast-enhanced (DCE) MRI, in the detection of clinically significant prostate cancer. In this article we describe the benefits of DCE as part of the PI-RADS lexicon, with particular reference to its role in PI-RADS V2 category 3 peripheral zone lesions. We also discuss the benefits of triplanar T2-weighted images, and finally discuss how a mpMRI protocol is of benefit in prostate cancer staging, in evaluating for local disease recurrence, and as a biomarker for neoadjuvant therapy response.
Insights
Dynamic contrast-enhanced (DCE) MRI enhances prostate cancer detection and staging within the PI-RADS framework. This abbreviated MRI approach improves the identification of clinically significant prostate cancer.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Abbreviated or biparametric prostate MRI protocols, often omitting dynamic contrast-enhanced (DCE) MRI, are gaining traction for detecting clinically significant prostate cancer.
- The PI-RADS (Prostate Imaging Reporting and Data System) lexicon is a widely used standard for interpreting prostate MRI findings.
Purpose of the Study:
- To elucidate the benefits of incorporating DCE-MRI into the PI-RADS lexicon for prostate cancer detection.
- To highlight the value of triplanar T2-weighted imaging.
- To discuss the utility of multiparametric MRI (mpMRI) in prostate cancer staging, recurrence evaluation, and assessing neoadjuvant therapy response.
Main Methods:
- Review and discussion of the role of DCE-MRI within the PI-RADS V2 guidelines.
- Analysis of PI-RADS V2 category 3 peripheral zone lesions.
- Examination of triplanar T2-weighted imaging benefits.
- Evaluation of mpMRI applications in staging, recurrence detection, and therapy response assessment.
Main Results:
- DCE-MRI provides crucial information, particularly for PI-RADS V2 category 3 lesions in the peripheral prostate zone.
- Triplanar T2-weighted images offer significant advantages in prostate MRI interpretation.
- Multiparametric MRI is beneficial for comprehensive prostate cancer management.
Conclusions:
- Dynamic contrast-enhanced MRI is a valuable component of multiparametric MRI for prostate cancer detection and characterization.
- The integration of DCE-MRI and triplanar T2-weighted imaging refines the PI-RADS assessment.
- Multiparametric MRI plays a critical role in staging, monitoring recurrence, and evaluating treatment efficacy in prostate cancer.
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI

